Ironwood Pharmaceuticals (IRWD)

• Market cap: $712M
• 1 day: 14.69%
• 5 days: 27.14%
• 1 month: 26.42%
• 3 months: 3.49%
• 6 months: -20.25%
• Year to date: -64.14%
• 1 year: -59.55%
• 5 years: -67.42%
• 10 years: -69.44%
• Sector: Healthcare
• Industry: Pharmaceutical Preparations

About: Ironwood Pharmaceuticals Inc is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth plan for expanding its research, development, manufacturing, and marketing capabilities.

Employees: 267

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

124,700% more call options, than puts

Call options by funds: $46.2M | Put options by funds: $37K

0% more funds holding in top 10

Funds holding in top 10: 1 [Q2] → 1 (+0) [Q3]

3% less funds holding

Funds holding: 227 [Q2] → 220 (-7) [Q3]

8.84% less ownership

Funds ownership: 110.93% [Q2] → 102.1% (-8.84%) [Q3]

11% less repeat investments, than reductions

Existing positions increased: 68 | Existing positions reduced: 76

15% less first-time investments, than exits

New positions opened: 40 | Existing positions closed: 47

42% less capital invested

Capital invested by funds: $1.15B [Q2] → $672M (-$477M) [Q3]